Top

Published in:

Open Access 01-12-2013 | Research

Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination

Authors: Mary Ní Fhlathartaigh, Jill McMahon, Richard Reynolds, David Connolly, Eibhlín Higgins, Timothy Counihan, Una FitzGerald

Published in: Acta Neuropathologica Communications | Issue 1/2013

Abstract

Background

Calreticulin (CRT) is a chaperone protein, which aids correct folding of glycosylated proteins in the endoplasmic reticulum (ER). Under conditions of ER stress, CRT is upregulated and may be displayed on the surface of cells or be secreted. This ‘ecto-CRT’ may activate the innate immune response or it may aid clearance of apoptotic cells. Our and other studies have demonstrated upregulation of ER stress markers CHOP, BiP, ATF4, XBP1 and phosphorylated e-IF2 alpha (p-eIF2 alpha) in biopsy and post-mortem human multiple sclerosis (MS) samples. We extend this work by analysing changes in expression of CRT, BiP, CHOP, XBP1 and p-eIF2 alpha in a rat model of inflammatory demyelination. Demyelination was induced in the spinal cord by intradermal injection of recombinant mouse MOG mixed with incomplete Freund’s adjuvant (IFA) at the base of the tail. Tissue samples were analysed by semi-quantitative scoring of immunohistochemically stained frozen tissue sections. Data generated following sampling of tissue from animals with spinal cord lesions, was compared to that obtained using tissue derived from IFA- or saline-injected controls. CRT present in rat serum and in a cohort of human serum derived from 14 multiple sclerosis patients and 11 healthy controls was measured by ELISA.

Results

Stained tissue scores revealed significantly (p<0.05) increased amounts of CRT, CHOP and p-eIF2 alpha in the lesion, lesion edge and normal-appearing white matter when compared to controls. CHOP and p-eIF2 alpha were also significantly raised in regions of grey matter and the central canal (p<0.05). Immunofluorescent dual-label staining confirmed expression of these markers in astrocytes, microglia or neurons. Dual staining of rat and human spinal cord lesions with Oil Red O and CRT antibody showed co-localisation of CRT with the rim of myelin fragments. ELISA testing of sera from control and EAE rats demonstrated significant down-regulation (p<0.05) of CRT in the serum of EAE animals, compared to saline and IFA controls. This contrasted with significantly increased amounts of CRT detected in the sera of MS patients (p<0.05), compared to controls.

Conclusion

This data highlights the potential importance of CRT and other ER stress proteins in inflammatory demyelination.

Available only for authorised users

Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, Warren KG, Power C: The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J Immunol 2007, 179: 1210–1224.CrossRefPubMed

Cunnea P, Mhaille AN, McQuaid S, Farrell M, McMahon J, FitzGerald U: Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult Scler 2011, 17: 808–818. 10.1177/1352458511399114CrossRefPubMed

McMahon J, McQuaid S, Reynolds R, Fitzgerald U: Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis. Mult Scler 2012, 17: 1437–1447.CrossRef

Mhaille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U: Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol 2008, 67: 200–211. 10.1097/NEN.0b013e318165b239CrossRefPubMed

Walter P, Ron D: The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011, 334: 1081–1086. 10.1126/science.1209038CrossRefPubMed

Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006, 7: 880–885. 10.1038/sj.embor.7400779PubMedCentralCrossRefPubMed

Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M: Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009, 417: 651–666. 10.1042/BJ20081847CrossRefPubMed

Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE: Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010, 24: 665–683. 10.1096/fj.09-145482PubMedCentralCrossRefPubMed

Wang WA, Groenendyk J, Michalak M: Calreticulin signaling in health and disease. Int J Biochem Cell Biol 2012, 44: 842–846. 10.1016/j.biocel.2012.02.009CrossRefPubMed

10.

Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM: Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123: 321–334. 10.1016/j.cell.2005.08.032CrossRefPubMed

11.

Ogden CA, de Cathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM: C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001, 194: 781–795. 10.1084/jem.194.6.781PubMedCentralCrossRefPubMed

12.

Kishore U, Sontheimer RD, Sastry KN, Zaner KS, Zappi EG, Hughes GR, Khamashta MA, Strong P, Reid KB, Eggleton P: Release of calreticulin from neutrophils may alter C1q-mediated immune functions. Biochem J 1997,322(Pt 2):543–550.PubMedCentralCrossRefPubMed

13.

Peters LR, Raghavan M: Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells. J Immunol 2011, 187: 919–931. 10.4049/jimmunol.1100690PubMedCentralCrossRefPubMed

14.

Holoshitz J, De Almeida DE, Ling S: A role for calreticulin in the pathogenesis of rheumatoid arthritis. Ann N Y Acad Sci 2010, 1209: 91–98. 10.1111/j.1749-6632.2010.05745.xPubMedCentralCrossRefPubMed

15.

Chakrabarty A, Danley MM, LeVine SM: Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis. J Neurosci Res 2004, 76: 822–833. 10.1002/jnr.20125CrossRefPubMed

16.

Chakrabarty A, Fleming K, Marquis J, LeVine S: Quantifying immunohistochemical staining of phospho-eIF2alpha, heme oxygenase-2 and NADPH cytochrome P450 reductase in oligodendrocytes during experimental autoimmune encephalomyelitis. J Neurosci Methods 2005, 144: 227–234. 10.1016/j.jneumeth.2004.11.010CrossRefPubMed

17.

Deslauriers AM, Afkhami-Goli A, Paul AM, Bhat RK, Acharjee S, Ellestad KK, Noorbakhsh F, Michalak M, Power C: Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration. J Immunol 2011, 187: 4788–4799. 10.4049/jimmunol.1004111CrossRefPubMed

18.

Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B: The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 2007, 117: 448–456. 10.1172/JCI29571PubMedCentralCrossRefPubMed

19.

Lin W, Kemper A, Dupree J, Harding H, Ron D, Popko B: Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006, 129: 1306–1318. 10.1093/brain/awl044CrossRefPubMed

20.

Lin W, Popko B: Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 2009, 12: 379–385. 10.1038/nn.2273PubMedCentralCrossRefPubMed

21.

Eggleton P, Lieu TS, Zappi EG, Sastry K, Coburn J, Zaner KS, Sontheimer RD, Capra JD, Ghebrehiwet B, Tauber AI: Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol 1994, 72: 405–409. 10.1006/clin.1994.1160CrossRefPubMed

22.

Andrin C, Pinkoski MJ, Burns K, Atkinson EA, Krahenbuhl O, Hudig D, Fraser SA, Winkler U, Tschopp J, Opas M, et al.: Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 1998, 37: 10386–10394. 10.1021/bi980595zCrossRefPubMed

23.

Sipione S, Ewen C, Shostak I, Michalak M, Bleackley RC: Impaired cytolytic activity in calreticulin-deficient CTLs. J Immunol 2005, 174: 3212–3219.CrossRefPubMed

24.

Paidassi H, Tacnet-Delorme P, Verneret M, Gaboriaud C, Houen G, Duus K, Ling WL, Arlaud GJ, Frachet P: Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition. J Mol Biol 2011, 408: 277–290. 10.1016/j.jmb.2011.02.029CrossRefPubMed

25.

Tarr JM, Young PJ, Morse R, Shaw DJ, Haigh R, Petrov PG, Johnson SJ, Winyard PG, Eggleton P: A mechanism of release of calreticulin from cells during apoptosis. J Mol Biol 2010, 401: 799–812. 10.1016/j.jmb.2010.06.064CrossRefPubMed

26.

Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al.: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007, 13: 54–61. 10.1038/nm1523CrossRefPubMed

27.

Tarr JM, Winyard PG, Ryan B, Harries LW, Haigh R, Viner N, Eggleton P: Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells. Arthritis Rheum 2010, 62: 2919–2929. 10.1002/art.27602CrossRefPubMed

28.

Shields AM, Panayi GS, Corrigall VM: Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis? Clin Exp Immunol 2011, 165: 292–300. 10.1111/j.1365-2249.2011.04433.xPubMedCentralCrossRefPubMed

29.

Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 2002, 31: 523–536. 10.1023/A:1025747832215CrossRefPubMed

30.

Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H: Multiple sclerosis: in situ evidence for antibody and complement-mediated demyelination. Annals of Neurology 1998, 43: 465–471. 10.1002/ana.410430409CrossRefPubMed

Title: Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination
Authors: Mary Ní Fhlathartaigh
Jill McMahon
Richard Reynolds
David Connolly
Eibhlín Higgins
Timothy Counihan
Una FitzGerald
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Acta Neuropathologica Communications / Issue 1/2013
Electronic ISSN: 2051-5960
DOI: https://doi.org/10.1186/2051-5960-1-37

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination

Abstract

Background

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease

The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice

Reelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer’s disease patients

Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease

ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies